These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18183714)

  • 1. C-reactive protein and acute coronary syndrome: comparison of conservative and interventional management.
    Munir TA; Afzal MN
    J Ayub Med Coll Abbottabad; 2007; 19(2):26-31. PubMed ID: 18183714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A; Sanaa I; Annabi N; Ousji M; Aloui H; Naffeti S
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):899-905. PubMed ID: 16231577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
    Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
    Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.
    Bogaty P; Boyer L; Simard S; Dauwe F; Dupuis R; Verret B; Huynh T; Bertrand F; Dagenais GR; Brophy JM
    J Am Coll Cardiol; 2008 Jun; 51(24):2339-46. PubMed ID: 18549920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kinetics of C-reactive protein release in different forms of acute coronary syndrome].
    Sánchez PL; Rodríguez MV; Villacorta E; Albarrán C; Cruz I; Moreiras JM; Martín F; Pabón P; Fernández-Avilés F; Martín-Luengo C
    Rev Esp Cardiol; 2006 May; 59(5):441-7. PubMed ID: 16750141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome.
    Wetterö J; Nilsson L; Jonasson L; Sjöwall C
    Clin Chim Acta; 2009 Feb; 400(1-2):128-31. PubMed ID: 18973750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of patients with acute chest pain of uncertain origin by means of serial measurement of high-sensitivity C-reactive protein].
    Lozano T; Ena J; Almenar V; Graells M; Molina J; Antorrena I; de la Guía F
    Rev Esp Cardiol; 2007 Aug; 60(8):817-24. PubMed ID: 17688850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity cytokine detection in acute coronary syndrome reveals up-regulation of interferon gamma and interleukin-10 post myocardial infarction.
    Patel KD; Duggan SP; Currid CA; Gallagher WM; McManus R; Kelleher D; Murphy RT; Ryan AW
    Clin Immunol; 2009 Nov; 133(2):251-6. PubMed ID: 19665935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
    Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
    Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome.
    Hochholzer W; Buettner HJ; Trenk D; Breidthardt T; Noveanu M; Laule K; Christ M; Schindler C; Neumann FJ; Mueller C
    Am J Cardiol; 2008 Jul; 102(2):173-9. PubMed ID: 18602516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
    Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
    Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.
    Mega JL; Morrow DA; de Lemos JA; Mohanavelu S; Cannon CP; Sabatine MS
    J Am Coll Cardiol; 2008 Jun; 51(25):2422-9. PubMed ID: 18565400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predischarge C-reactive protein and 1-year outcome after acute coronary syndromes.
    Steg PG; Ravaud P; Tedgui A; Puel J; Moyse D; Curaudeau E; Quentzel SW;
    Am J Med; 2006 Aug; 119(8):684-92. PubMed ID: 16887415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
    Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
    Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.